封面
市場調查報告書
商品編碼
1890942

主動脈瘤市場:按動脈瘤位置、治療方法、產品類型、診斷方法、年齡層、性別、最終用戶、通路和地區分類

Aortic Aneurysm Market, By Aneurysm Location, By Treatment Type, By Product Type, By Diagnosis Type, By Age Group, By Gender, By End User, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

主動脈瘤市場預計在 2025 年達到 49.4 億美元,預計到 2032 年將達到 112.7 億美元,2025 年至 2032 年的複合年成長率為 12.5%。

報告覆蓋範圍 報告詳情
基準年: 2024 2025年市場規模: 49.4億美元
歷史數據時期: 2020年至2024年 預測期: 2025年至2032年
預測期(2025-2032年)複合年成長率: 12.50% 預計2032年價值: 112.7億美元

全球主動脈瘤市場是心血管醫療設備業的重要組成部分,它致力於治療影響全球數百萬人的最危及生命的血管疾病之一。

主動脈瘤是指人體最大動脈-主動脈的血管壁變薄並向外凸出,若不及時治療,可能危及生命。該市場涵蓋一系列全面的診斷工具、手術器械、血管內血管支架以及微創治療方案,旨在檢測、監測和修復這些危險的動脈擴張。隨著全球人口老化以及心血管疾病、高血壓和動脈粥狀硬化盛行率的不斷上升,對先進的主動脈瘤治療方案的需求持續成長。

該市場涵蓋各種解剖位置,包括胸主動脈瘤 (TAA) 和腹部主動脈血管瘤(AAA),每一種都需要專門的治療方法和設備技術。

血管內動脈瘤修復術(EVAR)技術、開窗式和分支式血管支架以及混合手術技術的創新顯著改善了患者的預後,同時降低了手術風險。為了應對日益嚴重的主動脈瘤疾病負擔,全球醫療系統正在增加對篩檢計畫、先進影像技術和專科治療中心的投入,這推動了市場顯著成長和技術進步。

市場動態

全球主動脈瘤市場的成長主要受多種強勁因素驅動,這些因素共同支撐著市場穩健成長。全球人口老化是其中最重要的促進因素,因為老齡化與動脈壁退化和心血管危險因子累積導致的主動脈瘤發生率增加直接相關。高血壓、糖尿病、吸菸和動脈粥狀硬化性疾病的日益普遍進一步刺激了市場需求,而血管內修復技術的突破,包括開窗血管支架和複雜分叉裝置,正在提高治療的可及性和改善患者預後。

醫護人員和患者對篩檢通訊協定的認知不斷提高,以及CT血管造影術和超音波技術等診斷影像能力的改進,正在促進早期發現和介入率的提高。

然而,目前仍有許多市場限制,包括先進的血管內介入器械和手術高成本,這限制了發展中地區的醫療服務獲取,並給醫療系統的報銷帶來挑戰。創新醫療設備複雜的監管核准流程可能會延遲其上市時間,並增加製造商的研發成本。此外,血管內介入手術可能出現的併發症,例如內漏、器械移位以及對長期耐用性的擔憂,也會限制較保守的醫療機構的採用率。

儘管面臨這些挑戰,新興市場醫療基礎設施的擴建、政府加大心血管疾病預防主導以及醫療旅遊業的蓬勃發展,都帶來了巨大的機會。可生物分解支架技術、人工智慧輔助手術規劃以及基於基因分析的個人化治療方案的開發,為市場拓展和創新提供了廣闊的前景。

本次調查的主要特點

  • 本報告對全球主動脈瘤市場進行了詳細分析,以 2024 年為基準年,給出了預測期(2025-2032 年)內的市場規模(十億美元)和復合年成長率(%)。
  • 它重點介紹了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業的競爭策略的重要見解。
  • 該報告根據以下參數對全球主動脈瘤市場的主要企業進行了分析:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球主動脈瘤市場報告的目標受眾是該行業的各類相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球主動脈瘤市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 重大進展
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特分析
  • 併購趨勢
  • 產業趨勢

4. 2020-2032年全球主動脈瘤市場(依動脈瘤部位分類)

  • 腹部主動脈血管瘤
  • 胸主動脈瘤
  • 腹部主動脈血管瘤

5. 2020-2032年全球主動脈瘤市場(依治療方法)

  • 開放性手術修復
  • 血管內治療

6. 2020-2032年全球主動脈瘤市場(依產品類型分類)

  • 血管支架
  • 導管
  • 導管導引線
  • 球囊血管成形術裝置
  • 其他血管內附件

7. 2020-2032年全球主動脈瘤市場(依診斷方法分類)

  • 超音波(篩檢和監測)
  • 電腦斷層血管造影術(CTA)
  • 磁振血管造影術(MRA)
  • 常規導管血管血管造影術
  • 血管內超音波(IVUS)/術中影像

8. 2020-2032年全球主動脈瘤市場(依年齡層分類)

  • 60歲以下
  • 60至75歲
  • 75歲或以上

9. 2020-2032年全球主動脈瘤市場(依性別分類)

  • 男性
  • 女士

10. 2020-2032年全球主動脈瘤市場(依最終用戶分類)

  • 醫院
  • 專科心血管中心
  • 門診手術中心
  • 診斷影像中心
  • 研究和學術機構

11. 2020-2032年全球主動脈瘤市場(依通路分類)

  • 線上
  • 離線

12. 2020-2032年全球主動脈瘤市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第13章 競爭格局

  • Medtronic plc
  • Cook Medical LLC
  • L. Gore and Associates Inc.
  • Terumo Corporation
  • Endologix LLC
  • Cardinal Health Inc.
  • Becton Dickinson and Company(BD)
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • JOTEC GmbH(CryoLife/Artivion)
  • Lombard Medical Technologies
  • Cordis(a Cardinal Health company/Cordis Inc.)
  • Merit Medical Systems Inc.
  • LeMaitre Vascular Inc.

第14章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第15章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8957

Aortic Aneurysm Market is estimated to be valued at USD 4.94 Bn in 2025 and is expected to reach USD 11.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.94 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.50% 2032 Value Projection: USD 11.27 Bn

The global aortic aneurysm market represents a critical segment within the cardiovascular medical device industry, addressing one of the most life-threatening vascular conditions affecting millions worldwide.

An aortic aneurysm occurs when the wall of the aorta, the body's largest artery, weakens and bulges outward, creating a potentially fatal condition if left untreated. The market encompasses a comprehensive range of diagnostic tools, surgical devices, endovascular stent grafts, and minimally invasive treatment solutions designed to detect, monitor, and repair these dangerous arterial dilations. With aging populations globally experiencing increased prevalence of cardiovascular diseases, hypertension, and atherosclerosis, the demand for advanced aortic aneurysm management solutions continues to escalate.

The market spans various anatomical locations including thoracic aortic aneurysms (TAA) and abdominal aortic aneurysms (AAA), each requiring specialized therapeutic approaches and device technologies.

Innovation in endovascular aneurysm repair (EVAR) techniques, fenestrated and branched stent grafts, and hybrid surgical procedures has revolutionized patient outcomes while reducing procedural risks. Healthcare systems worldwide are increasingly investing in screening programs, advanced imaging technologies, and specialized treatment centers to address the growing burden of aortic aneurysmal disease, driving substantial market growth and technological advancement.

Market Dynamics

The global aortic aneurysm market growth is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The aging global population represents the most significant driver, as advanced age correlates directly with increased aortic aneurysm incidence due to arterial wall degeneration and accumulated cardiovascular risk factors. Rising prevalence of hypertension, diabetes, smoking, and atherosclerotic diseases further amplifies market demand, while technological breakthroughs in endovascular repair techniques, including fenestrated stent grafts and complex branched devices, enhance treatment accessibility and patient outcomes.

Growing awareness among healthcare professionals and patients about screening protocols, coupled with improved diagnostic imaging capabilities such as CT angiography and ultrasound technologies, drives early detection and intervention rates.

However, the market faces notable restraints including the high cost of advanced endovascular devices and surgical procedures, which limit accessibility in developing regions and create reimbursement challenges for healthcare systems. Complex regulatory approval processes for innovative medical devices can delay market entry and increase development costs for manufacturers. Additionally, potential complications associated with endovascular procedures, including endoleaks, device migration, and long-term durability concerns, may restrict adoption rates among conservative practitioners.

Despite these challenges, significant opportunities emerge through expanding healthcare infrastructure in emerging markets, increasing government initiatives for cardiovascular disease prevention, and growing medical tourism sectors. The development of biodegradable stent technologies, artificial intelligence-guided surgical planning, and personalized treatment approaches based on genetic profiling present lucrative avenues for market expansion and innovation.

Key Features of the Study

  • This report provides in-depth analysis of the global aortic aneurysm market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global aortic aneurysm market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic plc, Cook Medical LLC, W. L. Gore and Associates Inc., Terumo Corporation, Endologix LLC, Cardinal Health Inc., Becton Dickinson and Company (BD), Abbott Laboratories, Boston Scientific Corporation, Braun Melsungen AG, JOTEC GmbH (CryoLife / Artivion), Lombard Medical Technologies, Cordis (a Cardinal Health company / Cordis Inc.), Merit Medical Systems Inc., and LeMaitre Vascular Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global aortic aneurysm market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic aneurysm market

Market Segmentation

  • Aneurysm Location Insights (Revenue, USD Bn, 2020 - 2032)
    • Abdominal Aortic Aneurysm
    • Thoracic Aortic Aneurysm
    • Thoracoabdominal Aortic Aneurysm
  • Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Open Surgical Repair
    • Endovascular Aneurysm Repair
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Stent Grafts
    • Catheters
    • Guidewires
    • Balloon Angioplasty Devices
    • Other Endovascular Accessories
  • Diagnosis Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Ultrasound (Screening & Surveillance)
    • Computed Tomography Angiography (CTA)
    • Magnetic Resonance Angiography (MRA)
    • Conventional Catheter Angiography
    • Intravascular Ultrasound (IVUS)/Intraoperative Imaging
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Below 60 Years
    • 60-75 Years
    • Above 75 Years
  • Gender Insights (Revenue, USD Bn, 2020 - 2032)
    • Male
    • Female
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Specialty Cardiac and Vascular Centers
    • Ambulatory Surgical Centers
    • Diagnostic Imaging Centers
    • Research and Academic Institutes
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online
    • Offline
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Medtronic plc
    • Cook Medical LLC
    • L. Gore and Associates Inc.
    • Terumo Corporation
    • Endologix LLC
    • Cardinal Health Inc.
    • Becton Dickinson and Company (BD)
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Braun Melsungen AG
    • JOTEC GmbH (CryoLife / Artivion)
    • Lombard Medical Technologies
    • Cordis (a Cardinal Health company / Cordis Inc.)
    • Merit Medical Systems Inc.
    • LeMaitre Vascular Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Aortic Aneurysm Market, By Aneurysm Location
    • Global Aortic Aneurysm Market, By Treatment Type
    • Global Aortic Aneurysm Market, By Product Type
    • Global Aortic Aneurysm Market, By Diagnosis Type
    • Global Aortic Aneurysm Market, By Age Group
    • Global Aortic Aneurysm Market, By Gender
    • Global Aortic Aneurysm Market, By End User
    • Global Aortic Aneurysm Market, By Distribution Channel
    • Global Aortic Aneurysm Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Aortic Aneurysm Market, By Aneurysm Location, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Abdominal Aortic Aneurysm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thoracic Aortic Aneurysm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thoracoabdominal Aortic Aneurysm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Aortic Aneurysm Market, By Treatment Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Open Surgical Repair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Endovascular Aneurysm Repair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Aortic Aneurysm Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stent Grafts
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Guidewires
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Balloon Angioplasty Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Endovascular Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Aortic Aneurysm Market, By Diagnosis Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Ultrasound (Screening & Surveillance)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Computed Tomography Angiography (CTA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Magnetic Resonance Angiography (MRA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Conventional Catheter Angiography
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intravascular Ultrasound (IVUS)/Intraoperative Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Aortic Aneurysm Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Below 60 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 60-75 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Above 75 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Aortic Aneurysm Market, By Gender, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Aortic Aneurysm Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Cardiac and Vascular Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Aortic Aneurysm Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Aortic Aneurysm Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Aneurysm Location, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Diagnosis Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • L. Gore and Associates Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Endologix LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton Dickinson and Company (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • JOTEC GmbH (CryoLife / Artivion)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lombard Medical Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cordis (a Cardinal Health company / Cordis Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merit Medical Systems Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LeMaitre Vascular Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us